Drug Industry Tries to Slip $4 Billion Windfall Into Opioid Bill

Drug companies usually get what they want in public-policy battles on Capitol Hill, but a move by the pharmaceutical industry to grab $4 billion from the federal Treasury in a bill that is supposed to address the nation’s deadly opioid epidemic is meeting fierce resistance.

Read More

Blood, Sweat And Workplace Wellness: Where To Draw The Line On Incentives

Workplace wellness programs that offer employees a financial carrot for undergoing health screenings, sticking to exercise regimens or improving their cholesterol levels have long been controversial.

Read More

Ruling On Health Care Subsidies Could Prove Costly for Government

A federal court ruled this month that a Montana insurer is entitled to federal compensation for subsidy payments under the Affordable Care Act that President Trump abruptly ended last October, a ruling that could reverberate through insurance markets and cost the government hundreds of millions of dollars.

Read More

Administration Makes it Easier to Avoid ObamaCare Mandate Penalty

The Trump administration is making it easier for individuals to opt out of ObamaCare’s individual mandate.

Read More

Senate Passes Sweeping Opioids Package

In a rare moment of bipartisanship, the Senate overwhelmingly passed on Monday evening a sweeping package of bills aimed at addressing the nation’s deadly opioid epidemic.

Read More

Merger of Cigna and Express Scripts Gets Approval From Justice Dept.

Federal officials on Monday gave the go-ahead to the proposed merger between Cigna, one of the nation’s largest health insurers, and Express Scripts, a major pharmacy benefit manager.

Read More

House GOP Blocks Trump – Supported Drug Pricing Provision from Spending Bill

House Republicans on Thursday blocked a drug pricing amendment supported by President Trump from inclusion in a health-care spending bill.

Read More

Paper Jam: California’s Medicaid Program Hits ‘Print’ When The Feds Need Info

In the shadow of Silicon Valley, the hub of the world’s digital revolution, California officials still submit their records to the feds justifying billions in Medicaid spending the old-fashioned way: on paper.

Read More

New Medicare Advantage Tool To Lower Drug Prices Puts Crimp In Patients’ Choices

Starting next year, Medicare Advantage plans will be able to add restrictions on expensive, injectable drugs administered by doctors to treat cancer, rheumatoid arthritis, macular degeneration and other serious diseases.

Read More

California Grapples With Growing Physician Shortage For Low-Income Patients

When Paul Lyons opened a primary-care practice in the Palm Springs area for low-income patients, the need was clear.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square